Skip to content
Screener

Baxter International BAX Q3 2025 earnings

Reported October 30, 2025 · Before market open

Revenue$2.8BBeat by $10.2M
EPS$0.69Beat by $0.09
Revenue estimate$2.8B
EPS estimate$0.60

Next report

Oct 29, 2026 (in a month)
Revenue estimate$2.9B
EPS estimate$0.52

Financials

Q3 2025

Income statement

See full
Revenue$2.8B+5.0%
Gross profit$950.0M-8.0%
Operating income$172.0M+11.0%
Net income-$46.0M-133%
EPS (diluted)-$0.09-133%

Balance sheet

See full
Cash & equivalents$1.7B+21.5%
Total debt$214.0M-98.4%
Total equity$7.2B-8.0%
Total assets$21.1B-21.0%

Cash flow

See full
Operating cash flow$237.0M-6.3%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$11.7B-39.6%
Enterprise value$10.18B-67.3%
P/S1.1×-0.8×

Profitability

See full
Gross margin34.1%-4.8pp
Net margin-3.1%-4.1pp
FCF margin3.6%-6.2pp

Returns & leverage

See full
Return on equity-4.5%-5.9pp
Debt / equity0×-1.6×
Current ratio1.8×+0.4×

Segments

By product

See full
Infusion Therapies & Technologies$1.0B-4.4%
Care & Connectivity Solutions$473.0M+3.7%
Injectables & Anesthesia$333.0M+3.7%
Advanced Surgery$306.0M+12.5%
Front Line Care$300.0M+1.4%

By segment

See full
Medical Products & Therapies$1.3B-1.0%
Healthcare Systems & Technologies$773.0M+2.8%
Pharmaceuticals$632.0M+7.5%

FAQ

When did Baxter International report Q3 2025 earnings?
Baxter International (BAX) reported Q3 2025 earnings on October 30, 2025 before market open.
What were Baxter International's Q3 2025 revenue and EPS?
Baxter International reported revenue of $2.8B and eps of $0.69 for Q3 2025.
Did Baxter International beat estimates in Q3 2025?
Revenue beat the consensus estimate of $2.8B by $10.2M. EPS beat the consensus estimate of $0.60 by $0.09.
How did Baxter International's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.0% from $2.7B a year earlier and eps declined 13.8% from $0.80.
Where can I find Baxter International's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-047311) and the 10-Q periodic report (0001628280-25-048897) directly on SEC EDGAR. The filing index links above go to sec.gov.